Osteoarthritis Trial, Recruiting NCT06442319 Sponsor: Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06442319
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 45 years old
  • People with a body mass index (a measure of body weight relative to height) below 40
  • People who have had an ACL (knee ligament) reconstruction surgery
  • People who have small meniscal (knee cartilage) lesions that are not causing symptoms and do not need surgical repair
  • People who are willing to avoid any other injections or treatments into the knee joint for the entire duration of the study
  • People who are willing to stop taking pain relief medications, including anti-inflammatory drugs like ibuprofen, at least one month before a knee fluid collection procedure and for the rest of the study (tramadol and paracetamol are allowed)
  • People who are able to understand the study requirements and agree to take part voluntarily

Who may not be able to join:

  • People with a history of metabolic conditions, hormonal disorders, rheumatic or connective tissue diseases, cancer, or who use hormonal contraception, steroid medications, or antibiotics
  • People who have previously had an injection into the affected knee joint
  • People who have had previous surgery (other than ACL reconstruction) or a broken bone in the affected leg
  • People with a history of nicotine, alcohol, or drug addiction
  • People whose MRI scan shows a meniscal (knee cartilage) tear that requires stitching or full removal of the cartilage
  • People who have injuries to multiple knee ligaments or injuries to multiple parts of the body
  • People who have a significant inward or outward bowing of either knee greater than 10 degrees, as measured by X-ray

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 608075237

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz
Registry
ClinicalTrials.gov
Start date
1 June 2024
Est. completion
15 April 2028

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Pain and cartilage volume

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov